Propofol TIVA

ApprovedSmall molecule

YYonsei University

Propofol TIVA is one of 73 small molecule programs targeting Liver Transplant. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Liver TransplantActive, not recruiting

Kidney TransplantActive, not recruiting

Adolescent Idiopathic ScoliosisActive, not recruiting

Liver TransplantApproved

Active, not recruiting

Kidney TransplantApproved

Active, not recruiting

Adolescent Idiopathic ScoliosisPhase 2

Active, not recruiting

Competition

Competitive Landscape

476 competitors in Kidney Transplant

#DrugCompanyPhaseTrials

Propofol TIVA

YYonsei University

Approved

1 2

Nulojix

Bristol-Myers Squibb

Preclinical

16 3

Simulect

Novartis

Preclinical

15 4

Medrol

Pfizer

Preclinical

12 5

Zinbryta

Roche

Preclinical

6 6

Zemplar

AbbVie

Preclinical

2 7

Cysteine Hydrochloride

Novartis

Preclinical

1 8

Sensipar

Amgen

Preclinical

1 9

Epogen

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Preclinical

1 10

Radicava

Shionogi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Quality of Recovery1 trial

Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy

Completed·YYonsei University·N/A·NCT05280236·80 enrolled

Anesthesia1 trial

Bispectral Index Under Propofol Anesthesia in Children : a Study Between TIVA and TCI

Completed·PPr Isabelle CONSTANT·N/A·NCT02637726·66 enrolled

Efficacy and Safety1 trial

A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil

Completed·YYonsei University·N/A·NCT01920113·60 enrolled

Liver Transplant1 trial

A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver Transplantation

Completed·YYonsei University·Phase 4·NCT02504138·136 enrolled

Kidney Transplant1 trial

A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Renal Protection During Deceased Brain Dead Donor Kidney Transplantation - A Prospective, Randomized Trial

Completed·YYonsei University·Phase 4·NCT01870011·6 enrolled

1 more indication

Adolescent Idiopathic Scoliosis1 trial

Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery

Terminated·—·Phase 2·NCT06096181·13 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Propofol TIVA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propofol TIVA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propofol TIVA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yonsei University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: YYonsei University

Propofol TIVA

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Quality of Recovery1 trial

Anesthesia1 trial

Efficacy and Safety1 trial

Liver Transplant1 trial

Kidney Transplant1 trial

Adolescent Idiopathic Scoliosis1 trial

References

Drug Info

Quick Facts

Related News